Acro Biomedical (ACBM) Return on Equity (2016 - 2025)

Acro Biomedical has reported Return on Equity for 10 years, with the latest figure at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Equity for Q4 2025 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.35% in Q4 2023, with the low at 2.54% in Q3 2023.
• Average Return on Equity over 5 years is 0.2%, with a median of 0.01% recorded in 2021.
• Year-over-year, Return on Equity plunged 225 bps in 2023 and surged 255 bps in 2024.
• Tracing ACBM's Return on Equity over 5 years: stood at 0.13% in 2021, then slumped by 155 bps to 0.32% in 2022, then soared by 209 bps to 0.35% in 2023, then tumbled by 100 bps to 0.0% in 2024, then surged by 69 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.

Peer Comparison